The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

Last week, readers were most interested in a story about how the FDA could exert authority over LDTs in the future.

Labcorp also becomes a referral lab for the system's seven hospitals and clinical labs and will open three new patient service centers.